Insights into the mutations leading to capreomycin resistance in S-adenosyl-L-methionine binding motif in TlyA from Mycobacterium tuberculosis

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Engstrom, A., Perskvist, N., Werngren, J., Hoffner, S. E., & Jureen, P. (2011). Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. , 66(6), 1247–1254. https://doi.org/10.1093/jac/dkr109
   PubMed Web of Science ®Google Scholar
• Feuerriegel, S., Cox, H. S., Zarkua, N., Karimovich, H. A., Braker, K., Rusch-Gerdes, S., & Niemann, S. (2009). Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrobial Agents and Chemotherapy, 53(8), 3353–3356. https://doi.org/10.1128/AAC.00050-09
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Georghiou, S. B., Magana, M., Garfein, R. S., Catanzaro, D. G., Catanzaro, A., & Rodwell, T. C. (2012). Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: A systematic review. PLoS One, 7(3), e33275. https://doi.org/10.1371/journal.pone.0033275
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., & Tirado-Rives, J. (1988). The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. Journal of the American Chemical Society, 110(6), 1657–1666. https://doi.org/10.1021/ja00214a001
   PubMed Web of Science ®Google Scholar
• Kumar, S., Mittal, E., Deore, S., Kumar, A., Rahman, A., & Krishnasastry, M. V. (2015). Mycobacterial tlyA gene product is localized to the cell-wall without signal sequence. Frontiers in Cellular and Infection Microbiology, 5, 60.
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lin, Y., Li, Y., Zhu, N., Han, Y., Jiang, W., Wang, Y., Si, S., & Jiang, J. (2014). The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting interaction between ribosomal proteins L12 and L10. Antimicrobial Agents and Chemotherapy, 58(4), 2038–2044. https://doi.org/10.1128/AAC.02394-13
   PubMed Web of Science ®Google Scholar
• Llc, S. (2010). The PyMOL Molecular Graphics System.
   Google Scholar
• Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005). Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 49(2), 571–577. https://doi.org/10.1128/AAC.49.2.571-577.2005
   PubMed Web of Science ®Google Scholar
• Mj, B., & Rb, R. (2003). Amino acid properties and consequences of subsitutions. Bioinformatics for Geneticists. B. MR and G. IC, Wiley.
   Google Scholar
• Pablos-Mendez, A., Gowda, D. K., & Frieden, T. R. (2002). Controlling multidrug-resistant tuberculosis and access to expensive drugs: A rational framework. Bulletin of the World Health Organization, 80(6), 489–495. discussion 495–500.
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera–a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612.
   PubMed Web of Science ®Google Scholar
• Rahman, A., Srivastava, S. S., Sneh, A., Ahmed, N., & Krishnasastry, M. V. (2010). Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: A non-conventional hemolysin and a ribosomal RNA methyl transferase. BMC Biochemistry, 11(1), 35. [Database] https://doi.org/10.1186/1471-2091-11-35
   PubMedGoogle Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Stanley, R. E., Blaha, G., Grodzicki, R. L., Strickler, M. D., & Steitz, T. A. (2010). The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nature Structural & Molecular Biology, 17(3), 289–293.
   PubMed Web of Science ®Google Scholar
• WHO. (2020). Global tuberculosis report 2020: executive summary.
   Google Scholar
• Witek, M. A., Kuiper, E. G., Minten, E., Crispell, E. K., & Conn, G. L. (2017). A novel motif for S-adenosyl-l-methionine binding by the ribosomal RNA methyltransferase TlyA from Mycobacterium tuberculosis. The Journal of Biological Chemistry, 292(5), 1977–1987. https://doi.org/10.1074/jbc.M116.752659
   PubMed Web of Science ®Google Scholar